Eli Lilly and CompanyFinancials

Period:
Currency:
Units:
'85
'89
'93
'97
'01
'05
'09
'13
'17
'21

Select different items in the table to generate charts

Income Statement
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Dec 18
Dec 17
Dec 16
Dec 15
Revenue
45,042.7
34,124.1
28,541.4
28,318.4
24,539.8
22,319.5
21,493.3
19,973.8
21,222.1
19,958.7
Revenue % Change
32.00%
19.56%
0.79%
15.40%
9.95%
3.84%
7.61%
-5.88%
6.33%
1.75%
Cost of Revenue
8,418.3
7,082.2
6,629.8
7,312.8
5,483.3
4,721.2
4,681.7
4,447.7
5,710.1
5,037.2
Gross Profit
36,624.4
27,041.9
21,911.6
21,005.6
19,056.5
17,598.3
16,811.6
15,526.1
15,512
14,921.5
Gross Profit % Change
35.44%
23.41%
4.31%
10.23%
8.29%
4.68%
8.28%
0.09%
3.96%
1.62%
Gross Profit Margin
81.31%
79.25%
76.77%
74.18%
77.66%
78.85%
78.22%
77.73%
73.09%
74.76%
R&D Expenses
10,990.6
9,313.4
7,190.8
6,930.7
5,976.3
5,595
5,051.2
5,096.2
5,310.3
4,796.4
Selling, General, & Admin Expenses
8,132.1
6,941.2
6,067.5
6,141.9
5,869.4
6,003.9
5,734.6
6,180.1
6,330.4
6,533
Operating Income
17,501.7
10,787.3
8,653.3
7,933
7,210.8
5,999.4
6,025.8
4,249.8
3,871.3
3,592.1
Operating Income % Change
62.24%
24.66%
9.08%
10.02%
20.19%
-0.44%
41.79%
9.78%
7.77%
7.91%
Operating Income Margin
38.86%
31.61%
30.32%
28.01%
29.38%
26.88%
28.04%
21.28%
18.24%
18.00%
Total Other Income/Expenses Net
-4,821.3
-4,232.7
-1,846.9
-1,777.5
19.1
-733.5
-2,345.7
-1,945
-497.3
-802.1
Income Before Tax
12,680.4
6,554.6
6,806.4
6,155.5
7,229.9
5,265.9
3,680.1
2,304.8
3,374
2,790
Income Before Tax % Change
93.46%
-3.70%
10.57%
-14.86%
37.30%
43.09%
59.67%
-31.69%
20.93%
-7.01%
Income Before Tax Margin
28.15%
19.21%
23.85%
21.74%
29.46%
23.59%
17.12%
11.54%
15.90%
13.98%
Income Tax Expense
2,090.4
1,314.2
561.6
573.8
1,036.2
628
529.5
2,391.2
636.4
381.6
Net Income
10,590
5,240.4
6,244.8
5,581.7
6,193.7
8,318.4
3,232
-204.1
2,737.6
2,408.4
Net Income % Change
102.08%
-16.08%
11.88%
-9.88%
-25.54%
157.38%
-1683.54%
-107.46%
13.67%
0.75%
Net Income Margin
23.51%
15.36%
21.88%
19.71%
25.24%
37.27%
15.04%
-1.02%
12.90%
12.07%
Weighted Avg. Shares Out
900.61
899.38
950.18
953.65
956.59
957.53
1,027.72
1,052.02
1,100.88
1,105.27
EPS
11.76
5.83
6.57
5.85
6.47
8.69
3.14
-0.19
2.49
2.18
EPS % Change
101.72%
-11.26%
12.31%
-9.58%
-25.55%
176.75%
-1752.63%
-107.63%
14.22%
1.40%
Weighted Avg. Shares Out Dil
904.06
903.28
950.18
953.65
956.59
957.53
1,033.67
1,052.02
1,100.88
1,105.27
EPS Diluted
11.71
5.80
6.57
5.85
6.47
8.69
3.13
-0.19
2.49
2.18
Diluted EPS % Change
101.90%
-11.72%
12.31%
-9.58%
-25.55%
177.64%
-1747.37%
-107.63%
14.22%
1.40%
Net Income
10,590
5,240.4
6,244.8
5,581.7
6,193.7
8,318.4
3,232
-204.1
2,737.6
2,408.4
Income Tax Expense
2,090.4
1,314.2
561.6
573.8
1,036.2
628
529.5
2,391.2
636.4
381.6
Interest Income
175.2
173.6
62.8
25.4
33
80.4
159.3
166.4
108.7
87
Interest Expense
780.6
485.9
331.6
339.8
359.6
400.6
242.5
225
185.2
161.2
EBIT
12,075
6,242.3
6,537.6
5,841.1
6,903.3
4,945.7
3,596.9
2,246.2
3,297.5
2,715.8
EBIT % Change
93.44%
-4.52%
11.92%
-15.39%
39.58%
37.50%
60.13%
-31.88%
21.42%
-8.64%
EBIT Margin
26.81%
18.29%
22.91%
20.63%
28.13%
22.16%
16.73%
11.25%
15.54%
13.61%
Depreciation & Amortization
1,766.6
1,527.3
1,522.5
1,547.6
1,323.9
1,232.6
1,609
1,567.3
1,496.6
1,427.7
EBITDA
13,841.6
7,769.6
8,060.1
7,388.7
8,227.2
6,178.3
5,205.9
3,813.5
4,794.1
4,143.5
EBITDA % Change
78.15%
-3.60%
9.09%
-10.19%
33.16%
18.68%
36.51%
-20.45%
15.70%
-4.78%
EBITDA Margin
30.73%
22.77%
28.24%
26.09%
33.53%
27.68%
24.22%
19.09%
22.59%
20.76%